VU 0155041
Names
Biological Activity
[Description]:
VU0155041 is a potent, selective and mixed allosteric agonist/positive allosteric modulator (PAM) of mGluR4, with EC50s of 798 nM and 693 nM for human and rat mGluR4, respectively. VU0155041 is a partial agonist of mGluR4 that activates the receptor by interacting with a site that is distinct from the glutamate binding site[1].
[Related Catalog]:
[Target]
Human mGlu4:798 nM (EC50)
Rat mGlu4:693 nM (EC50)
[In Vitro]
VU0155041 (30 μM) causes 6.4-fold and 4.7-fold leftward shifts in the glutamate CRC at human and rat mGluR4, respectively[1]. VU0155041 (10 μM) does not affect NMDA receptor currents in striatal medium spiny neurons[1].
[In Vivo]
VU0155041 (31 nM, 93 nM; i.c.v.) reverses catalepsy induced by the dopamine D2 receptor antagonist haloperidol in rats[1]. VU0155041 (93 nM , 316 nM; i.c.v.) reverses reserpine-induced akinesia in rats[1]. Animal Model: Third ventricle cannulated (TVC) Male Sprague-Dawley rats (225-255 g)[1] Dosage: 31 nM, 93 nM Administration: Intracerebroventrical injection, after the haloperidol (1.5 mg/kg) treatment 2 hours Result: Decreased the cataleptic effects of haloperidol, and the effects still presented 30 min after infusion.
[References]
Chemical & Physical Properties
[ Molecular Formula ]:
C14H15Cl2NO3
[ Molecular Weight ]:
316.18000
[ Exact Mass ]:
315.04300
[ PSA ]:
69.89000
[ LogP ]:
4.47240
[ Storage condition ]:
-20℃